STEPHANIE GALLAGHER: Open Payments
NPI 1790152064 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 48 payments from 15 companies in 2025. Trend: 2023 $1,054 · 2024 $287 · 2025 $914
Food & beverage: $914
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $158 |
| Gilead Sciences, Inc. | 1 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| Merck Sharp & Dohme LLC | 4 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $58 |
| PFIZER INC. | 2 | $40 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $35 |
| Edwards Lifesciences Corporation | 1 | $33 |
Products named: Repatha, Kerendia, LEQVIO, VERQUVO, JARDIANCE, LifeVest, Attruby, FARXIGA.
Industry payments across NY — which companies pay providers there.
